Clinical Trial Update: Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the feasibility of using copper-64 labeled DOTATATE ([Cu64]DOTATATE) for intraoperative tracing of meningioma, currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• [Cu64]DOTATATE (Copper-64 DOTATATE)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Meningioma | Phase 4 | Status: RECRUITING